Cite
MLA Citation
Tobias Nordström et al.. “Prostate cancer screening using a combination of risk-prediction, MRI, and targeted prostate biopsies (STHLM3-MRI): a prospective, population-based, randomised, open-label, non-inferiority trial.” Lancet oncology, vol. 22, no. 9, 2021, pp. 1240–1249. http://access.bl.uk/ark:/81055/vdc_100144484585.0x000030